A five-year old British Columbia-based medical cannabis company just made its debut in the U.S. markets.

Tilray, which sell its products to patients, as well as researchers, governments, and pharmacies, opened on the NASDAQ on Thursday.

The company priced 9 million shares at $17 a share and they hit as high as $22.39. This represented an increase of 32%.

Tilray is the very first cannabis company to conduct an IPO in the United States. but cannot sell its products in the U.S. market, given that marijuana remains illegal under federal law.

So far 30 states and Washington, D.C. have legalized it in some form.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Marijuana Can Be Used For Military Vets With PTSD
01 May 2017
Autism can be Treated with Medical Pot in Minnesota
02 December 2017
This Company is Helping People Find Marijuana Dispensaries with Billboards
08 May 2018